Cillian King works as an Investor at Eqt Life Sciences. The firm's known portfolio counts 10 companies.
Is Cillian King a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Investor at Eqt Life Sciences, whose known portfolio counts 10 companies
- ONWARD
- Tubulis
- Artios Pharma
- Tenpoint Therapeutics
- Electra Therapeutics
- Exciva
- Kinaset Therapeutics
- FoRx Therapeutics
- Neurent Medical
- Xeltis
Investor Profile
Founders in the listed sector Healthcare, and focus areas Biotech, Clinical Trials, Drug Discovery and Genetics fall inside that listing.
Stage-wise, the deals at Eqt Life Sciences cluster around Growth, Late-Stage and Series A rounds.
The firm portfolio and the focus above give founders context on whether Cillian King matches their raise.
Colleagues at Eqt Life Sciences
Merijn Klaassen
CFO & COO EQT Life Sciences (formerly LSP)
Tilburg, Netherlands
Fouad Azzam
Partner
Boston, United States
John de Koning
Partner
Amsterdam, Netherlands
Anne Portwich
Partner
Amsterdam, Netherlands
Daniela Begolo
Managing Director
Amsterdam, Netherlands
Maximilian Moser
Vice President
London, United Kingdom
Philipp Bräuer
Vice President
Munich, Germany
Juliette Lee
VP
Amsterdam, Netherlands
Bruno Holthof
Partner
Oxford, United Kingdom
René Kuijten
Head of Life Sciences
Amsterdam, Netherlands
Drew Burdon
Partner
United Kingdom
Christoph Broja
Partner
Germany
Roberta Ferrari
Managing Director
United Kingdom
Laurenz Govaerts
Director
Brussels, Belgium
Kevin Hammon
Vice President
Boston, United States
Frequently asked questions
Who is Cillian King?
Cillian King is a private equity investor and venture capital investor based in Amsterdam, Netherlands, listed as Investor at Eqt Life Sciences. The known portfolio of that firm counts 10 companies. That portfolio belongs to the firm, not to Cillian King personally.
What does Cillian King invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Clinical Trials, Drug Discovery and Genetics. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Cillian King invest at?
Eqt Life Sciences appears in Growth, Late-Stage and Series A rounds across its known deals, and Cillian King is listed there as Investor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Cillian King listed at?
Cillian King is listed as Investor at Eqt Life Sciences. 15 other people in the database share a firm with Cillian King.
How do I contact Cillian King?
An email address, a phone number and a LinkedIn page are on file for Cillian King. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal